Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Cytori Cell Research Institute, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
3750 ADR120S,Inc. 【J-GAAP】
Earnings ReportADR120S,Inc. <3750> [TSE Std] announced its financial results after the market closed on November 14th (16:00). The consolidated net loss for the cumulative second quarter of the fiscal year ending March 2026 (April to September) was a reduced loss of 0.13 billion yen (compared to a loss of 0.43 billion yen in the same period last year).
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net income/loss for the October to March period (second half) is expected to turn into a profit of 0.20 billion yen (compared to a loss of 1.70 billion yen in the same period last year).
In the most recent three-month period, from July to September (2Q), the consolidated net loss expanded to a loss of 0.20 billion yen (compared to a loss of 0.19 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -323.1% in the same period last year to -1675.0%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2023 | 862 | -354 | -423 | -443 | -49.7 | ー | Nov 10, 2023 | J-GAAP |
| Apr - Sep, 2024 | 91 | -407 | -419 | -432 | -48.4 | ー | Nov 14, 2024 | J-GAAP |
| Apr - Sep, 2025 | 18 | -332 | -347 | -131 | -14.7 | ー | Nov 14, 2025 | J-GAAP |
| YoY | -80.2% | +18.4% | +17.2% | +69.7% | +69.7% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | - | 0 | May 15, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 18 | -332 | -347 | -131 | -14.7 | 0 | Nov 14, 2025 | J-GAAP |
| Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 31 | -399 | -445 | -1,708 | -191.3 | 0 | May 15, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 1,042 | 209 | 209 | 202 | 22.6 | - | Nov 14, 2025 | J-GAAP |
| YoY | +3,261.3% | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 1,560 | -772 | -906 | 138 | 15.5 | 0 | May 14, 2024 | J-GAAP |
| Mar, 2025 | 122 | -806 | -864 | -2,140 | -239.7 | 0 | May 15, 2025 | J-GAAP |
| Mar, 2026 Guidance | 1,060 | -123 | -138 | 71 | 8.0 | - | May 15, 2025 | J-GAAP |
| YoY | +768.9% | +84.7% | +84.0% | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 52 | -168 | -186 | -190 | -21.3 | -323.1 | Nov 14, 2024 | J-GAAP |
| Oct - Dec, 2024 | 24 | -195 | -217 | -319 | -35.8 | -812.5 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 7 | -204 | -228 | -1,389 | -155.6 | -2,914.3 | May 15, 2025 | J-GAAP |
| Apr - Jun, 2025 | 6 | -131 | -147 | 69 | 7.8 | -2,183.3 | Aug 14, 2025 | J-GAAP |
| Jul - Sep, 2025 | 12 | -201 | -200 | -200 | -22.4 | -1,675.0 | Nov 14, 2025 | J-GAAP |
| YoY | -76.9% | -19.6% | -7.5% | -5.3% | -5.3% |
Related Articles
ProjectHoldings, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 2.8 times
TOHOKU CHEMICAL, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 4% Increase in The Current Fiscal Year
Mental Health Tech, Ordinary Profit Forecast for the Fiscal Year Revised Downward to a 538 Million Yen, Dividend Revised to 10 Yen
Fast Fitness Japan, First Half Ordinary Profit Increases by 41%, Jul-Sep Ordinary Profit Increases by 35%
HANATOUR JAPAN, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 7%
miratap, Returning to Profitability This Year
SAN HOLDINGS, First Half Ordinary Profit Decreases by 5%, Jul-Sep Ordinary Profit Decreases by 12%
Linical, Ordinary Profit Forecast for the Fiscal Year Revised Downward to a Loss
Welby, Jan-Sep (Cumulative 3Q) Net Income Loss Narrows, Jul-Sep Net Income Loss Narrows
Living Tech, 45% Decrease in Ordinary Profit for The Current Fiscal Year